PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape.
Saved in:
| Title: | PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape. |
|---|---|
| Authors: | Skyles, Ty1 (AUTHOR), Bouchal, Samantha M.1,2 (AUTHOR), Giarratana, Anna3 (AUTHOR), Wengler, Jacob1 (AUTHOR), Hart, Ian1 (AUTHOR), Greig, Erin4 (AUTHOR), Singh, Harmanjeet5 (AUTHOR), Huang, Steve S.6 (AUTHOR), Martinez, Felipe6 (AUTHOR), Nguyen, Ba6 (AUTHOR), Shin, Clifford H.6 (AUTHOR), Yang, Ming6 (AUTHOR), Parent, Ephraim7 (AUTHOR), Robb, W. Hudson6 (AUTHOR), Franceschi, Ana M.8 (AUTHOR), Burkett, Brian9 (AUTHOR), Johnson, Derek9 (AUTHOR), Koran, Mary Ellen6 (AUTHOR) koran.maryellen@mayo.edu |
| Source: | Journal of Nuclear Medicine Technology. Mar2026, Vol. 54 Issue 1, p10-17. 8p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
